Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25
Published August 6, 2025 · Recall initiated: July 22, 2025
Summary
FDA records drug Class II recall D-0551-2025, published August 6, 2025 and initiated July 22, 2025. Recalling firm: Hikma Pharmaceuticals USA Inc.; Status: Ongoing; Reported quantity: 382,775 1mL vials; Lot: Lot # K24118, exp. date 10/31/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
What to do
Voluntary: Firm initiated · Letter
Get an email if LORAZEPAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LORAZEPAM
- Manufacturer
- Hikma Pharmaceuticals USA Inc.
- Distributor
- Distributed Nationwide in the USA
- Lot
- Lot # K24118, exp. date 10/31/2026
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDASucralfate Tablets, USP 1 gram, packaged in a) 100-count bottles NDC 29033-0003-01, and b) 500-count bottles,August 6, 2025
- FDASheehan Brothers Vending Cheeseburger, 4.7 oz (132g), individually wrapped in plastic, UPC: 100000952375August 6, 2025
- FDALorazepam Tablets, USP, 2mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDALorazepam Tablets, USP, 1mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDALorazepam Tablets, USP, 0.5mg, Unit Dose, 100 tablets per carton (10 x 10 blister packs), Rx only, The drugFebruary 26, 2025
- FDALorazepam Injection, USP, 2mg/mL, 1 mL vial (NDC 0641-6044-01), packaged in 25 x 1 mL Vials per carton (NDCMay 24, 2023
Questions about this recall
Was Lorazepam Injection, USP, 2 mg/mL, 25 x 1mL vials/carton, Rx Only, Manufactured by: Hikma Berkeley Heights, NJ 07922, NDC# 0641-6044-25 recalled?
Yes. FDA published recall D-0551-2025 on August 6, 2025. Reported hazard: Failed Impurities/Degradation Specifications: An out-of-Specification for total related compounds
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LORAZEPAM.